Literature DB >> 1652995

Malignant placental site trophoblastic tumor. A case report and a review of the literature.

L G Larsen1, K Theilade, L Skibsted, G K Jacobsen.   

Abstract

A clinicopathological and immunohistochemical study of a fatal case of placental site trophoblastic tumor (PSTT) is presented. PSTT is a rare variant of trophoblastic disease. Histologically the tumor is characterized by a monomorphic cell population, derived from the extravillous intermediate trophoblast. The tumor cells contain human placental lactogen (HPL) as the predominant marker, while human chorionic gonadotropin (HCG) is present only locally. PSTT has a malignant potential. In the case presented the tumor finally developed the biphasic pattern of choriocarcinoma. The clinical and pathological features of the malignant PSTT are reviewed. Establishing the diagnosis and predicting the biologic behavior of PSTT may be difficult. If metastases occur the prognosis is poor regardless of therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652995

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


  4 in total

1.  Placental site trophoblastic tumor. Clinical and pathological report of two cases.

Authors:  G Arató ; V Fülöp ; P Degrell ; I Szigetvári
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 2.  Placental site trophoblastic tumor.

Authors:  Nadereh Behtash; Mojgan Karimi Zarchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-16       Impact factor: 4.553

3.  Long term remission of metastatic placental site trophoblastic tumor (PSTT): Case report and review of literature.

Authors:  Nadereh Behtash; Fatemeh Ghaemmaghami; Malihe Hasanzadeh
Journal:  World J Surg Oncol       Date:  2005-06-15       Impact factor: 2.754

4.  Imaging and Clinical Data of Placental Site Trophoblastic Tumor: A Case Report.

Authors:  Maryam Niknejadi; Firoozeh Ahmadi; Farnaz Akhbari
Journal:  Iran J Radiol       Date:  2016-04-16       Impact factor: 0.212

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.